Investor's Business Daily on MSN
Two medical stocks skyrocket after demolishing views — and one is about to break out
Novocure and Glaukos led the Medical-Products industry group Thursday after the duo demolished Wall Street's first-quarter ...
Updated full-year 2026 revenue guidance to $690 million to $710 million, assuming continued GBM momentum and initial ...
Novocure (NASDAQ: NVCR) today reported financial results for the first quarter that ended March 31, 2026. Novocure is a global oncology company working to extend survival in some of the most ...
BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a ...
As of Thursday, April 30, NovoCure Limited’s NVCR share price has surged by 19.53%, which has investors questioning if this ...
Q1 2026 Management View “The leading news in the quarter was the FDA approval and subsequent U.S. launch of Optune Pax for patients with locally advanced pancreatic cancer.” (Executive Chairman ...
ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ:NVCR) announced today results from a retrospective post-hoc analysis of its phase 3 pivotal EF-14 trial data showing that increased compliance ...
After the close Wednesday, the FDA approved Optune Pax for the treatment of locally advanced pancreatic cancer — marking the first new treatment for the disease in almost 30 years. CEO Frank Leonard ...
CHAPEL HILL, N.C -- It's one of the most lethal cancers, and it affects about 20,000 Americans a year. Glioblastoma is an aggressive, fast-growing brain tumor. While there are treatments for ...
Novocure recently announced final results from a phase III EF-14 clinical trial of its Optune device for treatment of newly diagnosed glioblastoma (GBM). According to Novocure’s press release, the ...
LITTLETON, Colo. (CBS4)- A man with stage 4 brain cancer is beating the odds. Bruce Stahlman has extended his life expectancy with a treatment at UCHealth: a portable, painless device. He wears a ...
It’s one of the most lethal cancers, and it affects about 20,000 Americans a year. Glioblastoma is an aggressive, fast-growing brain tumor. While there are treatments for glioblastoma, there is no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results